Crossmark

Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients

Crossref DOI link: https://doi.org/10.1186/s13756-022-01187-8

Published Online: 2022-11-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gill, Christian M.

Nicolau, David P.

,
License Information

Text and Data Mining valid from 2022-11-30

Version of Record valid from 2022-11-30
More Information

Article History

Received: 27 June 2022

Accepted: 22 November 2022

First Online: 30 November 2022

Declarations

:

: This study was determined to be exempted as not constituting research involving human subjects by the Hartford Hospital IRB (Assurance #FWA00021932) and thus informed consent waived.

: Not applicable.

: CMG has received research grants from Cepheid, Everest Medicines, and Shionogi. DPN is a consultant, speaker bureau member and/or has received other research grants from Abbvie, Cepheid, Merck, Paratek, Pfizer, Wockhardt, and Shionogi.

Document is current

Any future updates will be listed below